Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001642247-17-000020

Director bought 30,000 shares at an average $0.44 ($13,236)

From the SEC's structured data for this filing

Trades in this filing

Vitale Philip J · Director

Table I: Non-derivative

15 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-16 Purchase : show line 1 in the form +100 $0.43 $43 40,100 D
2017-11-16 Purchase : show line 2 in the form +100 $0.43 $43 40,200 D
2017-11-16 Purchase : show line 3 in the form +8,480 $0.43 $3,646 48,680 D
2017-11-16 Purchase : show line 4 in the form +200 $0.43 $86 48,880 D
2017-11-16 Purchase : show line 5 in the form +400 $0.44 $176 49,280 D
2017-11-16 Purchase : show line 6 in the form +3,049 $0.44 $1,335 52,329 D
2017-11-16 Purchase : show line 7 in the form +18 $0.44 $8 52,347 D
2017-11-16 Purchase : show line 8 in the form +1,400 $0.44 $615 53,747 D
Open-market purchases · 30,000 sh · avg $0.44 · $13,236
Loading xslF345X03/primary_doc.xml…